Today the FDA has granted accelerated approval to Pfizer's HIV medicine Selzentry (or maraviroc). Hill & Knowlton has been assisting Pfizer with the drug, and it could be the first in a number of new HIV drugs to hit the market in the near future. You can see our past coverage here.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins